The protein-binding N-terminal domain of human translation elongation factor 1Bβ possesses a dynamic α-helical structural organization.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Apr 2019
Historique:
received: 07 08 2018
revised: 19 12 2018
accepted: 22 12 2018
pubmed: 28 12 2018
medline: 1 6 2019
entrez: 28 12 2018
Statut: ppublish

Résumé

Translation elongation factor 1Bβ (eEF1Bβ) is a metazoan-specific protein involved into the macromolecular eEF1B complex, containing also eEF1Bα and eEF1Bγ subunits. Both eEF1Bα and eEF1Bβ ensure the guanine nucleotide exchange on eEF1A while eEF1Bγ is thought to have a structural role. The structures of the eEF1Bβ catalytic C-terminal domain and neighboring central acidic region are known while the structure of the protein-binding N-terminal domain remains unidentified which prevents clear understanding of architecture of the eEF1B complex. Here we show that the N-terminal domain comprising initial 77 amino acids of eEF1Bβ, eEF1Bβ(1-77), is a monomer in solution with increased hydrodynamic volume. This domain binds eEF1Bγ in equimolar ratio. The CD spectra reveal that the secondary structure of eEF1Bβ(1-77) consists predominantly of α-helices and a portion of disordered region. Very rapid hydrogen/deuterium exchange for all eEF1Bβ(1-77) peptides favors a flexible tertiary organization of eEF1Bβ(1-77). Computational modeling of eEF1Bβ(1-77) suggests several conformation states each composed of three α-helices connected by flexible linkers. Altogether, the data imply that the protein-binding domain of eEF1Bβ shows flexible spatial organization which may be needed for interaction with eEF1Bγ or other protein partners.

Identifiants

pubmed: 30590147
pii: S0141-8130(18)34064-9
doi: 10.1016/j.ijbiomac.2018.12.220
pii:
doi:

Substances chimiques

Guanine Nucleotide Exchange Factors 0
Peptide Elongation Factor 1 0
Peptides 0
Recombinant Proteins 0
eEF1B-beta protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

899-907

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Tetiana V Bondarchuk (TV)

Institute of Molecular Biology and Genetics, NAS of Ukraine, 150, Zabolotnogo St., 03680 Kyiv, Ukraine.

Dmytro M Lozhko (DM)

Institute of Molecular Biology and Genetics, NAS of Ukraine, 150, Zabolotnogo St., 03680 Kyiv, Ukraine.

Vyacheslav F Shalak (VF)

Institute of Molecular Biology and Genetics, NAS of Ukraine, 150, Zabolotnogo St., 03680 Kyiv, Ukraine. Electronic address: shalak@imbg.org.ua.

Agnieszka Fatalska (A)

Institute of Biochemistry and Biophysics, PAN, Pawinskiego 5a, 02-109 Warsaw, Poland.

Roman H Szczepanowski (RH)

International Institute of Molecular and Cell Biology, Trojdena 4, 02-109 Warsaw, Poland.

Michał Dadlez (M)

Institute of Biochemistry and Biophysics, PAN, Pawinskiego 5a, 02-109 Warsaw, Poland.

Boris S Negrutskii (BS)

Institute of Molecular Biology and Genetics, NAS of Ukraine, 150, Zabolotnogo St., 03680 Kyiv, Ukraine.

Anna V El'skaya (AV)

Institute of Molecular Biology and Genetics, NAS of Ukraine, 150, Zabolotnogo St., 03680 Kyiv, Ukraine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH